SCHEMBL15945944

SCHEMBL15945944

FC1CCCCC1Nc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
TRPA1 O75762 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.42
BRD4 O60885 1/20 0.39
GFER P55789 1/20 0.38
HPGD P15428 1/20 0.38
POLB P06746 1/20 0.37
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
EPHX2 P34913 2/20 0.36
EPHX1 P07099 2/20 0.36
RAB9A P51151 1/20 0.36
TSHR P16473 1/20 0.36
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
CA1 P00915 1/20 0.35
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30887532 0.85 ALDH1A1 (0.65) ALDH1A1TRPA1SMN1; SMN2LMNAGAA
SCHEMBL16731052 0.80 ALDH1A1 (0.51) ALDH1A1TRPA1SMN1; SMN2LMNAGAA
SCHEMBL6426049 0.79 ALDH1A1 (0.41) ALDH1A1TRPA1SMN1; SMN2LMNAGAA
2-(Phenylamino)Cyclohexanol SCHEMBL432133 0.76 ALDH1A1 (0.51) ALDH1A1TRPA1SMN1; SMN2LMNAGAA
SCHEMBL4065548 0.76 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL4064618 0.76 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2LMNAGAA
2-(Phenylamino)Cyclohexanol SCHEMBL432132 0.76 ALDH1A1 (0.51) ALDH1A1TRPA1SMN1; SMN2LMNAGAA
SCHEMBL7020150 0.76 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL4064611 0.76 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2LMNAGAA
SCHEMBL7634555 0.76 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2LMNAGAAGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9133120-B2 Fentanyl derivatives as pH-dependent opioid receptor agonists Charité—Universitätsmedizin Berlin (DE) 2015-09-15 US disclosed
US-20140228406-A1 FENTANYL DERIVATIVES AS PH-DEPENDENT OPIOID RECEPTOR AGONISTS KONRAD-ZUSE-INSTITUT (DE) 2014-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228406-A1 FENTANYL DERIVATIVES AS PH-DEPENDENT OPIOID RECEPTOR AGONISTS OGFR, OPRK1, OPRM1 ALDH1A1 1551/4885TRPA1 23/4885SMN1; SMN2 3338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.